Mounjaro Without Insurance: 7 Real Ways to Pay in 2026
Lilly now sells Mounjaro to cash payers. Yet Zepbound, the same medicine, and compounded tirzepatide both cost less.
Medically reviewed by Jill Garnier, MDCompounded tirzepatide, a pharmacy-made copy of the medicine in Mounjaro, starts around $170 a month without insurance, but it is not FDA-approved. The cheapest brand-name option is Zepbound, the same medicine, at about $300 to $450 a month from Lilly. Mounjaro itself costs about $500 a month from Lilly, at every dose.
On this page
- What you'll actually pay
- Mounjaro without insurance: which option fits you?
- Each way to get Mounjaro without insurance, one by one
- What a full year of Mounjaro without insurance costs
- Why won't insurance cover Mounjaro for weight loss?
- Can you get insurance to cover Mounjaro anyway?
- Does Medicare cover Mounjaro?
- Is compounded tirzepatide legal and safe?
- Can you get Mounjaro free?
- Red flags when buying tirzepatide online without insurance
- Frequently asked questions
What you'll actually pay
We may earn a commission if you sign up through a link. It never affects the ranking. How we review
- Same medicine as Mounjaro
- About $450 from 7.5 mg if you refill within 45 days
- Late refill about $500 at 7.5 mg, $700 from 10 mg
- Lilly's own cash price
- Same at every dose
- Prescription needed
- Compounded, not FDA-approved
- Low price needs a year paid upfront
- About $250–$400 month to month, by form and dose
- No membership
- Compounded, not FDA-approved
- $79 membership included, first month free
- Price rises with the dose
- About $140/mo at the lowest dose with a prepaid year
- Compounded, not FDA-approved
- Tablets, sold as a 3-month plan
- About $300/mo if paid in full
- No membership
Show 2 more options
- Compounded, not FDA-approved
- Low price needs a year paid upfront
- About $390 month to month
- Dietitian and coaching included
- List price about $1,110
- GoodRx saves only about $20
- Same at every dose
Mounjaro without insurance: which option fits you?
- Lowest price: Mochi Health's compounded tirzepatide, about $170 a month at the lowest dose. The price rises as your dose goes up.
- Lowest price with no membership: Curex, about $250 a month for a tablet at the starting dose, or about $200 on a prepaid year.
- FDA-approved for less: Zepbound from LillyDirect, about $300 to $450 a month. It is the same medicine as Mounjaro.
- You need the Mounjaro name itself: LillyDirect Mounjaro, about $500 a month at every dose.
- You'd rather skip needles: Curex tirzepatide tablets, about $250 a month at the starting dose. Henry Meds sells them for about $350.
- You want coaching too: Fridays, about $240 a month when you prepay a year.
- Your commercial plan said no: the Mounjaro Savings Card brings the price to $499 a month, the same as LillyDirect.
Each way to get Mounjaro without insurance, one by one
LillyDirect Mounjaro self-pay: brand Mounjaro for about $500
Lilly sells Mounjaro to cash payers through LillyDirect, its online pharmacy. The price starts at $499 a month. It stays the same at every dose, from 2.5 to 15 mg.
It is open to people with no insurance. It is also open to people whose work or government plan won't cover Mounjaro. You still need a prescription.
LillyDirect Zepbound self-pay: the cheapest FDA-approved tirzepatide
Mounjaro and Zepbound are the same medicine, tirzepatide, made by Lilly at the same doses. Mounjaro is approved for type 2 diabetes. Zepbound is approved for weight loss, and for sleep apnea in adults with obesity.
Zepbound self-pay costs less than Mounjaro self-pay. You can get it as vials or as a KwikPen, a pen that holds a month of doses. Here is what LillyDirect charges for a month:
- 2.5 mg, the starting dose: $299
- 5 mg: $399
- 7.5 to 15 mg: $449, if each refill is ordered within 45 days of your last delivery
- Late refill at 7.5 mg or higher: about $500 at 7.5 mg, about $700 from 10 mg
Lilly's current self-pay terms run through December 31, 2026.
Mochi Health: the lowest starting price
Mochi Health prices compounded tirzepatide by dose. The medicine costs $90 a month at the lowest dose. It rises to $199 at the top dose.
A $79-a-month membership comes on top. All in, you pay about $170 a month at the lowest dose and about $280 at the top.
New members get the first month of membership free on the 1-month plan, though not in every state. Prepaying a year lowers the membership to about $49 a month.
Mochi is one of the companies Lilly sued in 2025 over how they marketed compounded tirzepatide. Read the full Mochi Health review before you sign up.
Curex: the cheapest option with no membership
Curex sells compounded tirzepatide as a shot or a dissolving tablet. Its price covers the online visit, the medicine and shipping. There is no membership fee.
Its "from $199" price needs a year paid upfront, at the lowest dose. Month to month, the tablet costs about $250 and the shot about $300 at the starting dose. Both cost about $100 more at higher doses. Lab tests are not included.
Fridays: coaching and a dietitian included
Fridays charges about $240 a month for compounded tirzepatide when you pay for a year upfront. Month to month, it costs about $390.
Both prices include provider visits, a one-on-one dietitian and group coaching.
The catch is the complaint record. Many BBB complaints about refunds and late shipments have gone unanswered. A year paid upfront is also hard to get back if you need to stop. Read the Fridays review first.
Henry Meds: tirzepatide tablets, no membership
Henry Meds sells compounded tirzepatide only as a tablet. It costs about $350 a month, sold as a 3-month plan.
Paying the 3 months in full lowers it to about $300 a month. There is no separate membership fee.
Henry does not publish prices by dose, so ask for the price at your likely dose. The tablet suits women who would rather skip needles. Lilly sued Henry Meds in 2025 too. See the full Henry Meds review.
Retail pharmacy and GoodRx: how much coupons really save
At a US pharmacy with no coverage, a 28-day carton of four Mounjaro pens costs about $1,110. That is Lilly's 2026 list price. It is the same at every dose.
A GoodRx coupon lowers it to about $1,090. That saves only about $20. Even the coupon price is more than twice Lilly's own cash price for Mounjaro.
What a full year of Mounjaro without insurance costs
Brand-name pens come in 28-day cartons, so a year takes 13 fills. The totals below run from cheapest to most expensive.
- Mochi Health, prepaid membership year: about $1,670 at the lowest dose, up to about $2,980 at the top dose
- Mochi Health, month to month: about $1,950 at the lowest dose, up to about $3,260 at the top dose, counting the free first month
- Curex, prepaid year: about $2,390 at the lowest dose, about $3,590 at higher doses
- Fridays: about $2,880 on the prepaid year, about $4,670 month to month
- Henry Meds tablets: about $4,190, or about $3,560 if each 3-month plan is paid in full
- LillyDirect Zepbound, staying at 5 mg: about $5,100 in the first year
- LillyDirect Zepbound, at 7.5 mg or higher from your third fill: about $5,650 in the first year
- LillyDirect Mounjaro: about $6,490, the same at every dose
- GoodRx coupon: about $14,170
- Retail, no program: about $14,460
Two limits apply to the Zepbound totals. Lilly's KwikPen self-pay terms cover up to 11 fills in a calendar year, while a full year takes 13. The current terms also end December 31, 2026.
The gap between full retail and the cheapest path runs past $10,000 a year. Almost none of it comes from coupons. It comes from knowing that Lilly sells Mounjaro for $499 a month, and Zepbound for less.
Why won't insurance cover Mounjaro for weight loss?
Mounjaro is FDA-approved for adults and children 10 and older with type 2 diabetes. It helps control blood sugar. Since August 2026, it is also approved to lower the risk of heart attack, stroke and heart-related death in adults with type 2 diabetes and high heart risk.
It is not approved for weight loss. Insurance drug lists, called formularies, follow approved uses. So a plan may pay for Mounjaro for diabetes and deny the same prescription for weight loss.
A denial for weight-loss use is not a mistake by your insurer. It is how most plans are built.
Even with type 2 diabetes, you may hit hurdles. Prior authorization means your plan wants proof of need before it pays. Step therapy means you must try an older, cheaper diabetes drug first. While that plays out, paying cash can be the faster route.
Can you get insurance to cover Mounjaro anyway?
A denial is not always the end. Start by finding out why it happened.
Coverage follows the diagnosis code your prescriber sends with the claim. Type 2 diabetes is code E11, and obesity is code E66. Most plans treat them very differently, even for the same drug.
If you have type 2 diabetes and the claim was coded for weight loss by mistake, your prescriber can resubmit it with the right code.
If the denial is correct under your plan, you can still appeal. For most plans, you have 180 days from the denial notice to file an internal appeal. Strong appeals include your health conditions, the treatments you have tried and a clear reason from your prescriber.
Ask your prescriber's office whether an appeal is realistic. Also ask whether a step-therapy rule, not a flat exclusion, is what blocks coverage.
Commercial insurance also opens the Mounjaro Savings Card. If your plan covers Mounjaro, the card can bring your copay as low as $25, up to a savings limit. If your plan won't cover it, the card brings the price to $499 a month.
The card needs an active commercial plan, so it does not help with no insurance at all. Its current terms end December 31, 2026. See the full Mounjaro Savings Card breakdown to learn which tier applies to you.
Does Medicare cover Mounjaro?
Medicare Part D, Medicare's drug coverage, cannot cover Mounjaro used only for weight loss. It can cover it for type 2 diabetes if it is on your plan's drug list.
In 2026, your yearly costs for covered Part D drugs stop at $2,100.
Medicare's $50-a-month GLP-1 Bridge does not include Mounjaro. It covers Wegovy, Foundayo and the Zepbound KwikPen. Type 2 diabetes is not one of the conditions that qualify.
Is compounded tirzepatide legal and safe?
Compounded tirzepatide is made by a pharmacy, not by Lilly. The FDA does not review compounded drugs for safety, effectiveness or quality before they are sold.
During the tirzepatide shortage, pharmacies made copies on a large scale. The FDA first found the shortage over in October 2024. It confirmed that finding on December 19, 2024, after a legal challenge from compounders.
Large-scale copying then had to stop. State-licensed 503A pharmacies, which fill prescriptions for single patients, had until February 18, 2025. Larger 503B outsourcing facilities had until March 19, 2025.
What remains is narrower. A 503A pharmacy can still make tirzepatide for one named patient when the prescriber documents a medical need the brand cannot meet. An allergy to an inactive ingredient is one example. A lower price does not count.
Lilly has also gone to court. In April 2025, it sued Mochi Health, Henry Meds, Fella Health and Willow over how they marketed compounded tirzepatide.
The cases have gone different ways. A judge dismissed the Willow case in February 2026, and Lilly has appealed. The Henry Meds case has a jury trial set for October 2027. The Mochi case is set for trial in January 2028.
Our compounded Mounjaro guide compares these sellers in more depth.
Can you get Mounjaro free?
Not right now. Lilly Cares is Lilly's charity that gives free medicine to some people with low incomes. Its current list of medicines does not include Mounjaro or Zepbound.
If you have type 2 diabetes and no coverage, the list does include Trulicity. It is an older weekly shot from the same drug family. Ask your doctor whether it fits you.
Red flags when buying tirzepatide online without insurance
Cheap tirzepatide has drawn real fraud, not just pushy marketing. Watch for these signs, whichever path you choose.
- No prescription needed. Walk away from any seller that skips a clinician review. That is not legal, and it raises the risk of fakes and dosing errors.
- Fake compounded products. The FDA warns of fraudulent compounded tirzepatide sold in the US. One product named a pharmacy that never made it.
- No pharmacy name. Be careful with any seller that won't name the state-licensed pharmacy filling your prescription.
- Prices far below this page. A price well under every figure here, with no explanation, is a sign the product may not be real.
- Cost sold as the medical reason. A seller that presents compounding as a way to save money has it backward. The legal path needs a medical reason that applies to you.
Frequently asked questions
What is the cash price of Mounjaro without insurance?+–
The list price is about $1,110 for a 28-day carton, the same at every dose. A GoodRx coupon lowers it only to about $1,090. Lilly sells Mounjaro for $499 a month through LillyDirect, so few people should pay the list price.
Can I buy Mounjaro self-pay directly from Lilly, the way Zepbound works?+–
Yes. LillyDirect sells Mounjaro for $499 a month at every dose. It is open to people with no insurance and to people whose plan won't cover it. You need a prescription. Zepbound, the same medicine, costs $299 to $449 a month there, by dose.
Is compounded tirzepatide still legal in 2026?+–
Only under a narrow exception. The FDA confirmed the tirzepatide shortage was over on December 19, 2024. A 503A pharmacy can still make it for one named patient with a documented medical need the brand cannot meet. A lower price does not count. Lilly's lawsuits against Mochi Health and Henry Meds are still open. Its case against Willow was dismissed in February 2026, and Lilly has appealed.
Can I get Mounjaro free if I don't have insurance?+–
Not through Lilly right now. Lilly Cares, Lilly's free-medicine charity, does not list Mounjaro or Zepbound among its medicines. If you have type 2 diabetes, it does list Trulicity, an older weekly shot. Ask your doctor whether it fits you.
What's the cheapest legitimate way to get tirzepatide without insurance?+–
Mochi Health's compounded tirzepatide has the lowest starting price, about $170 a month with its membership. It rises with your dose, up to about $280. Curex, with no membership, costs about $250 a month for a tablet, or about $200 on a prepaid year. For an FDA-approved brand, Zepbound from LillyDirect starts at $299 a month.
Will my insurance ever cover Mounjaro if I've already been denied?+–
It's possible. Denials often trace back to the diagnosis code on the claim. If you have type 2 diabetes and the claim was coded for weight loss, fixing the code can solve it. If the denial matches your plan's rules, most plans give you 180 days to file an internal appeal. Back it with real medical records before you settle on paying cash long term.
Is Mounjaro or Zepbound cheaper without insurance?+–
Zepbound is cheaper on LillyDirect, as long as you refill on time. Mounjaro costs $499 a month at every dose. Zepbound costs $299 to $449 a month by dose, if each refill from 7.5 mg is ordered within 45 days. Miss that window and Zepbound costs $699 from 10 mg, more than Mounjaro. Zepbound is approved for weight loss, so it fits when that is your goal. See the Mounjaro cost breakdown for prices with insurance.